Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinoma

Oncology

Volumn 76, Issue 1, 2008, Pages 1-9

  Sohn, Joo Hyuk ^a   Choi, Hye Jin ^a   Lee, Jong Tae ^b   Lee, Jong Doo ^b   Kim, Joo Hang ^a   Moon, Young Myung ^a   Park, Kyungsoo ^b   Park, Kyung Bae ^c   Kim, Eunhee ^c   Yoo, Nae Choon ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Korea Atomic Energy Research Institute   (South Korea)

Author keywords

Hepatocellular carcinoma; Holmium 166 chitosan complex; Internal radiation therapy; Intraarterial injection

Indexed keywords

CHITOSAN; HOLMIUM 166; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT DURATION; TUMOR VOLUME; VOMITING;

ADULT; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHITOSAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; HOLMIUM; HUMANS; LIVER FUNCTION TESTS; MODELS, THEORETICAL; PATIENT SELECTION; RADIOISOTOPES; RADIOTHERAPY DOSAGE; SURVIVAL RATE; YOUNG ADULT;

EID: 56149119694     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000173735     Document Type: Article

References (23)

1. Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet 2003;362:1907-1917.
2. Shin HR, Ahn YO, Bae JM, Shin MH, Lee DH, Lee CW, Ohrr H, Ahn DH, Ferlay J, Parkin DM, Oh DK, Park JG: Cancer incidence in Korea. Cancer Res Treat 2002;34:405-408.
3. Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-442.
4. Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, SolàR, Rodés J, Bruix J, Barcelona Liver Cancer Group: Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002;359:1734-1738.
5. Khodjibekova M, Szyszko T, Khan S, Nijran K, Tait P, Al-Nahhas A: Selective internal radiation therapy with yttrium-90 for unresectable liver tumours. Rev Recent Clin Trials 2007;2:212-216.
6. Salem R, Thurston KG, Carr BI, Goin JE, Geschwind JF: Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 2002;13:S223-S229.
7. Shepherd FA, Rotstein LE, Houle S, Yip TC, Paul K, Sniderman KW: A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer 1992;70:2250-2254.
8. Lau WY, Leung WT, Ho S, Leung NW, Chan M, Lin J, Metreweli C, Johnson P, Li AK: Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 1994;70:994-999.
9. 131I-labeled- ionized oil in the treatment of hepatocellular carcinoma. Hepatology 1997;26:1156-1161.
10. Mumper RJ, Ryo UY, Jay M: Neutron-activated holmium-166-poly (L-lactic acid) microspheres: a potential agent for the internal radiation therapy of hepatic tumors. J Nucl Med 1991;32:2139-2143.
11. Nijsen JF, Zonnenberg BA, Woittiez JR, Rook DW, Swildens-van Woudenberg IA, van Rijk PP, van het Schip AD: Holmium-166 poly lactic acid microspheres applicable for intraarterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques. Eur J Nucl Med 1999;26:699-704.
12. Nijsen F, Rook D, Brandt C, Meijer R, Dullens H, Zonnenberg B, de Klerk J, van Rijk P, Hennink W, van het Schip F: Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study. Eur J Nucl Med 2001;28:743-749.
13. Suzuki YS, Momose Y, Higashi N, Shigematsu A, Park KB, Kim YM, Kim JR, Ryu JM: Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice. J Nucl Med 1998;39:2161-2166.
14. Kim JK, Han KH, Lee JT, Paik YH, Ahn SH, Lee JD, Lee KS, Chon CY, Moon YM: Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma. Clin Cancer Res 2006;12:543-548.
15. Nelson WR, Hirayama H, Rogers DWO: The EGS4 Code System. Stanford, Standford Linear Accelerator Center, 1985, SLAC 256.
16. 166Ho-chitosan complex and its macroaggregates for a potential use of internal radiotherapy. Kor J Nucl Med 1996;30:351-360.
17. WHO Handbook for the Results of Cancer Treatment. Geneva, World Health Organization, 1979, WHO Offset Publ No 48.
18. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001;35:421-430.
19. Cancer Therapy Evaluation Program. Common Toxicity Criteria, vers 2.0. Bethesda, National Institutes of Health, 1998.
20. Lee HS, Kim KM, Yoon JH, Lee TR, Suh KS, Lee KU, Chung JW, Park JH, Kim CY: Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study. J Clin Oncol 2002;20:4459-4465.
21. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, Pompili M, Brunello F, Lazzaroni S, Torzilli G: Hepatoellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101-108.
22. Lencioni R, Pinto F, Armillotta N, Bassi AM, Moretti M, Giulio MD, Marchi S, Uliana S, Della Capanna M, Lencioni M, Bartolozzi C: Long-term results of percutaneous ethanol injection therapy for hepatocelular carcinoma in cirrhosis: a European experience. Eur Radiol 1997;7:514-519.
23. Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A: Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001;11:914-921.